Request a free trial Log in
Products
Solutions
Data
News & Analysis
About
Blog

Log in Request a free trial

News & Analysis

driven by the PitchBook Platform

Research Center

All All articles
VC Venture capital
PE Private equity
M&A M&A
Tech Tech
Europe Europe
Credit Credit
Data & Tools Data & Tools

Research Center Subscribe

Sonoma Bio picks up $265M for inflammatory disease treatment

August 5, 2021

Share:

Sonoma Biotherapeutics has raised a $265 million Series B led by Ally Bridge Group, with participation from ArrowMark, Avidity Partners, Casdin Capital, Deep Track Capital, GV, NS Investment and others. Operating out of South San Francisco and Seattle, the company develops T cell therapies for autoimmune and inflammatory diseases. Sonoma raised $70 million in a Series A last year.

Select Additional Investors

Fidelity Management & Research, Frazier Healthcare Partners, Janus Henderson Investors, Mirae Asset Global Investments, Osage University Partners, Piper Sandler, Vertex Ventures HC

Share:





Tags:

Venture Capital

Join the more than 1.5 million industry professionals who get our daily newsletter!

First name

Last name

Business email

I agree to PitchBook's privacy policy

Related content

Chrome Extension
CRM Integration
Direct Data
Excel and Powerpoint Plugins
Morningstar Institutional Equity Research
PitchBook Credit
PitchBook Desktop
PitchBook Institutional Research
PitchBook Mobile
Product Releases

PitchBook for

Hedge Funds
Private Equity
Private Market Valuations
Startups
Venture Capital

Profile Previews

Asset Allocation
Benchmarking
Business Development
Deal Execution
Deal Sourcing
Due Diligence
Fundraising
Networking
Private Market Intel

Blog Webinars Video Library

Advisors
Companies
Data Operations
Deals
Debt
Financials
Funds
Investors
Lenders
Limited Partners
M&A
Professionals

News & Analysis

Advertise
LCD News & Research
News Archive
News Team
Newsletter
Report Methodologies
Reports
Research & Analysis Team

Careers
Customer Success
Partnerships
Press Inquiries

How PitchBook Compares

Case Studies
Customer Testimonials
PitchBook vs. Competitors
Pricing
What Sets Us Apart

Follow us







US Headquarters

+1 (206) 623.1986
901 Fifth Avenue
Suite 1200
Seattle, WA 98164

European Headquarters

+44 (0) 20 8037.2308
1st Floor Saffron House
6-10 Kirby Street
London EC1N 8TS
United Kingdom

Asia-Pacific Headquarters

80 Raffles Place
#41-01 UOB Plaza 1
Singapore 048624

[email protected]
Request Research
Profile Request
Deal Submission

Follow us







© 2025 PitchBook. Win what’s next. All rights reserved.

Terms of Use
Privacy Policy
California Consumer: Do Not Sell My Info